HSBC Holdings’s Moderna MRNA Stock Holding History

HSBC Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Buy	+21,000	New	+$980K	﹤0.01%	1844
2025 Q1	–	Sell	-46,100	Closed	-$1.89M	–	3191
2024 Q4	$1.89M	Buy	+46,100	New	+$2.2M	﹤0.01%	1499
2024 Q2	–	Sell	-1,600	Closed	-$170K	–	3095
2024 Q1	$170K	Buy	+1,600	New	+$161K	﹤0.01%	2731
2023 Q1	–	Sell	-11,900	Closed	-$2.1M	–	2909
2022 Q4	$2.1M	Buy	11,900 +1,300	+12%	+$213K	﹤0.01%	1669
2022 Q3	$1.28M	Hold	10,600	–	–	﹤0.01%	1726
2022 Q2	$1.54M	Buy	10,600 +7,200	+212%	+$1.03M	﹤0.01%	1710
2022 Q1	$596K	Buy	3,400 +1,700	+100%	+$286K	﹤0.01%	2289
2021 Q4	$434K	Buy	+1,700	New	+$497K	﹤0.01%	2555
2021 Q3	–	Sell	-4,900	Closed	-$1.15M	–	3097
2021 Q2	$1.15M	Buy	4,900 +1,600	+48%	+$286K	﹤0.01%	1694
2021 Q1	$427K	Buy	+3,300	New	+$478K	﹤0.01%	2080

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSBC Holdings's MRNA Position: Q1 2026 in Review

HSBC Holdings reduced its Moderna (MRNA) stake by 23% in Q1 2026, selling an estimated $6.92M and leaving 490,088 shares worth $24.6M. The position accounts for 0.01% of the portfolio, ranked #686.

HSBC Holdings first reported a position in MRNA in Q1 2020 and has held it in 25 quarters since. The position peaked at $141M in Q3 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

HSBC Holdings held 490,088 shares of Moderna worth $24.6M as of Q1 2026.
HSBC Holdings sold 148,282 Moderna shares in Q1 2026, an estimated $6.92M.
Moderna made up 0.01% of HSBC Holdings's portfolio in Q1 2026, its #686 holding.
HSBC Holdings first reported a position in Moderna in Q1 2020 and has held it in 25 quarters since.
HSBC Holdings's Moderna position peaked at $141M in Q3 2021.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.